【受診を希望する患者さんはこちら】

英文原著(2017年)             


                                    >>業績メニューに戻る

 ※ in press、Epub ahead of printは含めておりません。

  1. Dong Y, Kanda A, Noda K, Saito W, Ishida S. Pathologic roles of receptor-associated prorenin system in idiopathic epiretinal membrane. Sci Rep. 2017; 7: 44266
  2. Dong Y, Noda K, Murata M, Yoshida S, Saito W, Kanda A, Ishida S. Localization of acrolein-lysine adduct in fibrovascular tissues of proliferative diabetic retinopathy. Curr Eye Res. 2017; 42: 111-117
  3. Hashimoto Y, Saito W, Saito M, Hasegawa Y, Takita A, Mori S, Noda K, Ishida S. Relationship between choroidal thickness and visual field impairment in acute zonal occult outer retinopathy. J Ophthalmol. 2017; 2017:2371032. 
  4. Higashi K, Meguro A, Takeuchi M, Yamane T, Kitaichi N, Horie Y, Namba K, Ohno S, Nakao K, Sakamoto T, Sakai T, Tsuneoka H, Keino H, Okada AA, akeda A, Fukuhara T, Mashimo H, Ohguro N, Oono S, Enaida H, Okinami S, Mizuki N. Investigation of association between IL10 gene polymorphisms and Vogt-Koyanagi-Harada disease in a Japanese population. Ophthalmic Genet. 2017; 38: 187-189
  5. Hirooka K, Saito W, Namba K, Mizuuchi K, Iwata D, Hashimoto Y, Ishida S. Early post-treatment choroidal thickness to alert sunset glow fundus in patients with Vogt-Koyanagi-Harada disease treated with systemic corticosteroids. PLoS One. 2017; 12: e0172612
  6. Horie Y, Meguro A, Ohta T, Lee EB, Namba K, Mizuuchi K, Iwata D, Mizuki N, Ota M, Inoko H, Ishida S, Ohno S, Kitaichi N. HLA-B51 carriers are susceptible to ocular symptoms of Behcet disease and the association between the two becomes stronger towards the east along the Silk Road: a literature survey. Ocul Immunol Inflamm. 2017; 25: 37-40
  7. Ishiguro Y, Homma S, Yoshida T, Ohno Y, Ichikawa N, Kawamura H, Hata H, Kase S, Ishida S, Okada-Kannno H, Hatanaka K, Taketomi A. Usefulness of PET/CT for early detection of internal malignancies in patients with Muir–Torre syndrome: report of two cases. Surg Case Rep. 2017; 3: 71
  8. Ishikawa Y, Hashimoto Y, Saito W, Ando R, Ishida S. Blood flow velocity and thickness of the choroid in a patient with chorioretinopathy associated with ocular blunt trauma. BMC Ophthalmol. 2017; 17: 86
  9. Kanda A, Ishizuka ET, Shibata A, Matsumoto T, Toyofuku H, Noda K, Namba K, Ishida S. A novel single-strand RNAi therapeutic agent targeting the (pro)renin receptor suppresses ocular inflammation. Mol Ther Nucleic Acids. 2017; 7: 116-126
  10. Kanno-Okada H, Takakuwa E, Tagawa Y, Kase S, Hatanaka KC, Hatanaka Y, Namba K, Mitsuhashi T, Matsuno Y. Cytopathologic findingsof cell block materials from the vitreous: Diagnostic distinction between intraocular lymphoma and non-lymphomatous diseases. Pathol Int. 2017; 67: 342-349
  11. Kase S, Chin S, Hamanaka T, Shinmei Y, Ohguchi T, Kijima R, Matsuda A, Ishida S. Histological findings in the trabecular meshwork of a patient with atopic glaucoma. Open Ophthalmol J. 2017; 11: 103-106
  12. Kase S, Ohguchi T, Ishida S. Catastrophic thermal corneoscleral injury treated with transplantation of donor scleral graft. Case Rep Ophthalmol. 2017; 8: 349-352
  13. Kase S, Saito W, Mori S, Saito M, Ando R, Dong Z, Suzuki T, Hashimoto Y, Noda K, Ishida S. Clinical and histological evaluation of large macular holes surgery using the inverted ILM flap technique. Clin Ophthalmol. 2016; 11: 9–14(記載漏れ)
  14. Kase S, Shinohara T, Kase M, Ishida S. Effect of topical rebamipide on goblet cells in the lid wiper of human conjunctiva. Exp Ther Med. 2017; 13: 3516-3522
  15. Kase S, Shinohara T, Noda M, Ishida S, Kase M. Vascular anomaly in the levator aponeurosis of neurofibromatosis type 1. Int J Ophthalmol. 2017;10:656−657
  16. Kinoshita S, Ohguchi T, Noda K, Murata M, Yasueda S, Obata H, Matsunaga T, Fukushima T, Kanda A, Ishida S. Evaluation of the safety and tolerability of conjunctival ring for posterior segment of the eye. Curr Eye Res. 2017; 30: 1-6
  17. Matsuda T, Noda K, Murata M, Kawasaki A, Kanda A, Mashima Y, Ishida S. Vascular adhesion protein-1 blockade suppresses ocular inflammation after retinal laser photocoagulation in mice. Invest Ophthalmol Vis Sci. 2017; 58: 3254-3261
  18. Miyazaki D, Fukushima A, Ohashi Y, Ebihara N, Uchio E, Okamoto S, Shoji J, Takamura E, Nakagawa Y, Namba K, Fujishima H. Steroid-sparing effect of 0.1% tacrolimus eye drop for treatment of shield ulcer and corneal epitheliopathy in refractory allergic ocular diseases. Ophthalmology. 2017; 124: 287-294
  19. Ogura Y, Shiraga F, Terasaki H, Ohji M, Ishida S, Sakamoto T, Hirakata A, Ishibashi T. Clinical practice pattern in management of diabetic macular edema in Japan: survey results of Japanese retinal specialists. Jpn J Ophthalmol. 2017; 61: 43-50
  20. Suimon Y, Saito W, Hirooka K, Kanda A, Kitai H, Sakakibara-Konishi J, Ishida S. Improvements of visual function and outer retinal morphology following spontaneous regression of cancer in anti-recoverin cancer-associated retinopathy. Am J Ophthalmol Case Rep. 2017; 5: 137-140
  21. Tagawa Y, Namba K, Nakazono Y, Iwata D, Ishida S. Evaluating the efficacy of epinastine ophthalmic solution using a conjunctivitis allergen challenge model in patients with birch pollen allergic conjunctivitis. Allergol Int. 2017; 66: 338-343
Copyright(C)2009 Department of Ophthalmology, Hokkaido University School of Medicine.All Rights Reserved.